[1,2,3]-triazolo[4,5-d] pyrimidine compounds
US6713483B1 · kind B1 · utility
5Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2002 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | May 13, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides [1,2,3]-triazolo[4,5-d]pyrimidine analogue compounds of formula (I) The invention is also directed to pharmaceutical compositions containing the compounds, processes for the preparation of the compounds and methods of treatment employing the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.